iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Rhea-AI Summary

iRhythm Holdings (NASDAQ: IRTC) will release fourth quarter and full year 2025 financial results after market close on February 19, 2026. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET with a live and archived webcast available on the company’s investor site.

Key Figures

Earnings release date: February 19, 2026 Conference call time PT: 1:30 p.m. PT Conference call time ET: 4:30 p.m. ET

3 metrics

Earnings release date February 19, 2026 Q4 and full-year 2025 financial results release after market close

Conference call time PT 1:30 p.m. PT Start time for Q4 and full-year 2025 results call

Conference call time ET 4:30 p.m. ET Start time for Q4 and full-year 2025 results call

Market Reality Check

Price: $146.75 Vol: Volume 902,617 is 1.13x t...

normal vol

$146.75 Last Close

Volume Volume 902,617 is 1.13x the 20-day average of 797,015. normal

Technical Price $146.75 is trading below the 200-day MA of $160.12 and about 30.78% below the 52-week high of $212.

Peers on Argus

IRTC fell 5.48% while several close medical device peers also traded lower but m...

IRTC fell 5.48% while several close medical device peers also traded lower but more mildly (e.g., GKOS -1.2%, MASI -1.08%, BIO -1.84%, BRKR -3.25%), and GMED rose 0.77%, pointing to largely stock-specific weakness rather than a broad sector move.

Historical Context

5 past events · Latest: Jan 12 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 12	Prelim results & outlook	Positive	-5.8%	Preliminary Q4 2025 revenue beat guidance and raised 2026 outlook.
Dec 29	Conference presentation	Neutral	-0.0%	Announcement of J.P. Morgan Healthcare Conference presentation schedule.
Nov 21	Clinical data APHRS	Positive	+4.8%	Large APHRS 2025 analysis supporting Zio LTCM performance across populations.
Nov 11	Real‑world study data	Positive	+0.0%	Publication and AHA data highlighting benefits of longer-term Zio monitoring.
Nov 04	Investor conferences	Neutral	-0.3%	Participation in multiple upcoming investor conferences with webcast access.

Pattern Detected

Positive fundamental or clinical news has sometimes seen muted or negative next-day reactions, while neutral event announcements have generally coincided with modest stock moves.

Recent Company History

Recent news shows a mix of financial and clinical milestones. On Jan 12, 2026 (news_id 955785), iRhythm shared preliminary Q4 2025 highlights and >guidance above prior levels, yet the stock moved -5.82% the next day, indicating a divergence from positive fundamentals. Earlier in November 2025, large real‑world and regional Zio monitoring datasets (news_ids 939648, 933832) aligned with flat to positive reactions. Today’s earnings-date announcement slots into this cadence of scheduled investor updates.

Market Pulse Summary

This announcement sets February 19, 2026 as the key date for Q4 and full‑year 2025 results, with a c...

Analysis

This announcement sets February 19, 2026 as the key date for Q4 and full‑year 2025 results, with a conference call at 1:30 p.m. PT / 4:30 p.m. ET. Historically, iRhythm’s stock reaction has not always matched the tone of news; for example, a positive preliminary Q4 2025 update on Jan 12, 2026 was followed by a -5.82% move. Ahead of the call, attention typically centers on revenue trends, profitability metrics, cash flow, and any updated outlook versus prior guidance.

AI-generated analysis. Not financial advice.

SAN FRANCISCO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2025 after the close of trading on Thursday, February 19, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Holdings, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com

Media Contact
Kassandra Perry
mediarelations@irhythmtech.com 

FAQ

When will iRhythm (IRTC) report Q4 and full year 2025 results?

iRhythm will report Q4 and full year 2025 results after market close on February 19, 2026. According to the company, the release timing follows market close and precedes the scheduled investor conference call that same day.

What time is the iRhythm (IRTC) earnings conference call on February 19, 2026?

The conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET on February 19, 2026. According to the company, management will host the call and provide a live webcast and archived recording on its investor website.

Where can investors access the iRhythm (IRTC) webcast for the February 19, 2026 call?

Investors can access a live and archived webcast on the company’s investor website under the Quarterly Results section. According to the company, the webcast will be available at investors.irhythmtech.com for live and later playback.

Will iRhythm (IRTC) provide an archived recording of the February 19, 2026 call?

Yes. An archived webcast will be available after the live call on the company’s investor site. According to the company, the recording will be posted in the Quarterly Results section for on-demand access by interested parties.

Who will present on the iRhythm (IRTC) February 19, 2026 conference call?

The company’s management team will present on the scheduled conference call at 1:30 p.m. PT / 4:30 p.m. ET. According to the company, senior management will discuss fourth quarter and full year 2025 financial results and related matters.